158 related articles for article (PubMed ID: 34939018)
1. Collapsing Focal Segmental Glomerulosclerosis and Acute Kidney Injury Associated With Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Case Report.
Acharya R; Horn B; Zeng X; Upadhyay K
Kidney Med; 2021; 3(6):1086-1090. PubMed ID: 34939018
[TBL] [Abstract][Full Text] [Related]
2. Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent and young adult patients with B-cell acute lymphoblastic leukemia.
Petgrave YP; Selukar S; Epperly R; Naik S; Santos ND; Triplett BM; Gottschalk S; Bissler J; Talleur AC
Res Sq; 2023 Oct; ():. PubMed ID: 37886451
[TBL] [Abstract][Full Text] [Related]
3. Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma.
Gupta S; Seethapathy H; Strohbehn IA; Frigault MJ; O'Donnell EK; Jacobson CA; Motwani SS; Parikh SM; Curhan GC; Reynolds KL; Leaf DE; Sise ME
Am J Kidney Dis; 2020 Jul; 76(1):63-71. PubMed ID: 31973908
[TBL] [Abstract][Full Text] [Related]
4. Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemia.
Danylesko I; Chowers G; Shouval R; Besser MJ; Jacoby E; Shimoni A; Nagler A; Avigdor A
Curr Res Transl Med; 2020 Jan; 68(1):17-22. PubMed ID: 31882377
[TBL] [Abstract][Full Text] [Related]
5. Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient.
Melilli E; Mussetti A; Linares GS; Ruella M; La Salette C; Savchenko A; Taco MDR; Montero N; Grinyo J; Fava A; Gomà M; Meneghini M; Manonelles A; Cruzado J; Sureda A; Bestard O
Kidney Med; 2021; 3(4):665-668. PubMed ID: 34401733
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis.
Magoon S; Bichu P; Malhotra V; Alhashimi F; Hu Y; Khanna S; Berhanu K
Kidney Med; 2020; 2(4):488-492. PubMed ID: 32775989
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis.
Anagnostou T; Riaz IB; Hashmi SK; Murad MH; Kenderian SS
Lancet Haematol; 2020 Nov; 7(11):e816-e826. PubMed ID: 33091355
[TBL] [Abstract][Full Text] [Related]
9. Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies.
León-Román J; Iacoboni G; Bermejo S; Carpio C; Bolufer M; García-Carro C; Sánchez-Salinas M; Alonso-Martínez C; Bestard O; Barba P; Soler MJ
Clin Kidney J; 2024 Mar; 17(3):sfae027. PubMed ID: 38500492
[TBL] [Abstract][Full Text] [Related]
10. Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib.
El Chaer F; Holtzman NG; Sausville EA; Law JY; Lee ST; Duong VH; Baer MR; Koka R; Singh ZN; Hardy NM; Emadi A
Acta Haematol; 2019; 141(2):107-110. PubMed ID: 30695783
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Collapsing Focal Segmental Glomerulosclerosis After Initiation of Ado-Trastuzumab Emtansine Therapy.
Hakroush S; Wulf S; Gallwas J; Tampe B
Front Oncol; 2021; 11():796223. PubMed ID: 34912725
[TBL] [Abstract][Full Text] [Related]
12. CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome.
Chen L; Xu B; Long X; Gu J; Lou Y; Wang D; Cao Y; Wang N; Li C; Wang G; Wang Y; Zhu L; Wang J; An H; Xiao M; Xiao Y; Zhou J
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32345625
[TBL] [Abstract][Full Text] [Related]
13. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.
Lee DW; Kochenderfer JN; Stetler-Stevenson M; Cui YK; Delbrook C; Feldman SA; Fry TJ; Orentas R; Sabatino M; Shah NN; Steinberg SM; Stroncek D; Tschernia N; Yuan C; Zhang H; Zhang L; Rosenberg SA; Wayne AS; Mackall CL
Lancet; 2015 Feb; 385(9967):517-528. PubMed ID: 25319501
[TBL] [Abstract][Full Text] [Related]
14. CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease.
Pehlivan KC; Duncan BB; Lee DW
Curr Hematol Malig Rep; 2018 Oct; 13(5):396-406. PubMed ID: 30120708
[TBL] [Abstract][Full Text] [Related]
15. Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy.
Liu Y; Chen X; Wang D; Li H; Huang J; Zhang Z; Qiao Y; Zhang H; Zeng Y; Tang C; Yang S; Wan X; Chen YH; Zhang Y
J Immunother; 2018; 41(9):406-410. PubMed ID: 30198955
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD19 chimeric antigen receptors T cells for the treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: report of three cases.
Zhang J; Yang F; Qiu HY; Wu Q; Kong DQ; Zhou J; Han Y; Wu DP
Leuk Lymphoma; 2019 Jun; 60(6):1454-1461. PubMed ID: 30714847
[TBL] [Abstract][Full Text] [Related]
17. Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies.
Viardot A; Locatelli F; Stieglmaier J; Zaman F; Jabbour E
Ann Hematol; 2020 Oct; 99(10):2215-2229. PubMed ID: 32856140
[TBL] [Abstract][Full Text] [Related]
18. Safety of CAR-T Cell Therapy in Patients With Renal Failure/Acute Kidney Injury: Focused Review.
Khan I; Khan N; Wolfson N; Djebabria K; Rehman MEU; Anwer F
Clin Hematol Int; 2023 Jun; 5(2-3):122-129. PubMed ID: 37010812
[TBL] [Abstract][Full Text] [Related]
19. Cytokine release syndrome: Who is at risk and how to treat.
Frey N
Best Pract Res Clin Haematol; 2017 Dec; 30(4):336-340. PubMed ID: 29156206
[TBL] [Abstract][Full Text] [Related]
20. Acute kidney injury after CAR-T cell infusion.
Rousseau A; Zafrani L
Bull Cancer; 2022 Oct; ():. PubMed ID: 36220698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
